Baseline Characteristics Module
The Baseline Characteristics Module provides demographic and baseline characteristics information for participants in a clinical trial. This module includes data such as population descriptions and the types of units analyzed, helping researchers understand the baseline characteristics of study participants.
Baseline Characteristics Module path is as follows:
Study -> Results Section -> Baseline Characteristics Module
Baseline Characteristics Module
Ignite Creation Date:
2025-12-24 @ 7:55 PM
Ignite Modification Date:
2025-12-25 @ 5:30 PM
NCT ID:
NCT03224104
Population Description:
In Group A - TG02 + RT - 100 mg, we included patients who received the initial 100 mg TG02 dose. In Group A - TG02 + RT - 150 mg, we included patients who received the initial 150 mg TG02 dose. Similarly, in Group B - TG02 + TMZ -100 mg, we included patients treated at the starting TG02 dose of 100 mg. In Group B - TG02 + TMZ -150 mg, we included patients treated at the starting TG02 dose of 150 mg. In group C we included patients who received the initial TG02 dose of 150 mg.
Study:
NCT03224104
Study Brief:
Results Section:
NCT03224104